XU1

CAS No. 53439-81-9

XU1( —— )

Catalog No. M34473 CAS No. 53439-81-9

XU1(Benzo[c][1,8]naphthyridin-6(5h)-One) is an Aurora protein kinase inhibitor used for the treatment of diseases suitable for inhibition, regulation or modulation of kinase signaling.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 499 In Stock
5MG 744 In Stock
10MG 1036 In Stock
25MG 1518 In Stock
50MG 2052 In Stock
100MG 2655 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    XU1
  • Note
    Research use only, not for human use.
  • Brief Description
    XU1(Benzo[c][1,8]naphthyridin-6(5h)-One) is an Aurora protein kinase inhibitor used for the treatment of diseases suitable for inhibition, regulation or modulation of kinase signaling.
  • Description
    XU1(Benzo[c][1,8]naphthyridin-6(5h)-One) is an Aurora protein kinase inhibitor used for the treatment of diseases suitable for inhibition, regulation or modulation of kinase signaling.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Aurora Kinase
  • Recptor
    Aurora Kinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    53439-81-9
  • Formula Weight
    196.2
  • Molecular Formula
    C12H8N2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C2=C(C=3C(N1)=NC=CC3)C=CC=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • SNS-314

    SNS-314 is a potent, selective pan-Aurora kinase inhibitor with IC50 of 9 and 31 nM for Aurora A and Aurora B, repectively.

  • Aurora B inhibitor 1

    Aurora B inhibitor 1 is an Aurora B (Aurora-1) inhibitor (Ki <0.010 μM) with potential anticancer activity for cancer research.

  • AS 703569

    Cenisertib (AS 703569;R763) is a novel potent, orally available inhibitor of Aurora kinases, exhibits signifficant anti-proliferative activity against a wide range of tumor cells both in vitro and in vivo (A549 EC50=9 nM).